Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

36,447 stories, page 139 of 608

Advanced search

🌍Aug 31discoverynews.google.com

Seizure-related phenomena associated with propofol: insights from the FDA Adverse Event Reporting System (FAERS)

link.springer.comOriginal source

🌍Aug 31discoverynews.google.com

Canaccord reiterates Alnylam stock Buy rating after cardiology data

Investing.comOriginal source

🌍Aug 31discoverynews.google.com

Eli Lilly buying Merida Biosciences for up to $2.875 billion

qz.comOriginal source

🌍Aug 31discoverynews.google.com

Evonik boosts lipid-based drug manufacturing in Canada

Fibre2FashionOriginal source

🌍Aug 31discoverynews.google.com

Amgen Repatha trial shows 20% lower death risk

grafa.comOriginal source

🌍Aug 31discoverynews.google.com

Verastem shifts from speculative biotech to com...

PluangOriginal source

🌍Aug 31discoverynews.google.com

Chula Wins at IPSF Asia Pacific Pharmaceutical Symposium - Chulalongkorn University

จุฬาลงกรณ์มหาวิทยาลัยOriginal source

🌍Aug 31discoverynews.google.com

Karyopharm Submits Supplemental New Drug Application to the FDA for XPOVIO® (selinexor) Plus Ruxolitinib for Patients with Myelofibrosis

investors.karyopharm.comOriginal source

🌍Aug 31discoverynews.google.com

Maharashtra FDA steps up festive food safety checks, puts focus on licensed operators

Bureaucrats IndiaOriginal source

🌍Aug 31discoverynews.google.com

Karyopharm Submits Supplemental New Drug Application to the FDA for XPOVIO® (selinexor) Plus Ruxolitinib for Patients with Myelofibrosis

TradingViewOriginal source

🌍Aug 31discoverynews.google.com

Origin Agritech opens biotech research center in Guizhou By Investing.com

Investing.com IndiaOriginal source

🌍Aug 31discoverynews.google.com

Hair loss drugs are the next Ozempic. Biotech stocks are climbing

ThePrintOriginal source

🌍Aug 31discoverynews.google.com

Silicone Tubing for Pharmaceutical Use Market Outlook to 2035

IndexBoxOriginal source

🌍Aug 31discoverynews.google.com

Cipla Inks Licensing Deal for HER2 Cancer Drug TQB2102

WhalesbookOriginal source

🌍Aug 31discoverynews.google.com

Axsome Therapeutics Initiates SUMMIT Phase 3 Trial of AXS-05 in Smoking Cessation

The Manila TimesOriginal source

🌍Aug 31discoverynews.google.com

Is Eli Lilly (NYSE:LLY) the Pharmaceutical Bellwether as Approvals Sweep Healthcare?

Kalkine MediaOriginal source

🇺🇸Aug 31Researchaacr.org

Unboxing Cancer News, August 2026: Fishy Cancer, Federal- vs. Industry-funded Trials, and More

AACROriginal source

🌍Aug 31Researchanswers.childrenshospital.org

Rethinking platelet transfusions in newborns

Boston Children's HospitalOriginal source

🌍Aug 31discoverynews.google.com

Biotech Startup Investment Held Steady Even As AI Funding Surged

news.crunchbase.comOriginal source

🌍Aug 31discoverynews.google.com

Origin Agritech tests 10,000 corn samples as 300 distributors cover Guizhou

Stock TitanOriginal source

🌍Aug 31discoverynews.google.com

Origin Agritech Establishes R&D Center in Guizhou with Biotech Unit and State-Backed Seed Joint Venture

Yahoo FinanceOriginal source

🌍Aug 31discoverynews.google.com

Alterity Therapeutics (NASDAQ: ATHE) lines up pivotal Phase 3 trial in rare MSA

Stock TitanOriginal source

🌍Aug 31discoverynews.google.com

PANDA Therapeutics secures €160K to advance multi-target Alzheimer’s therapy

Tech.euOriginal source

🌍Aug 31discoverynews.google.com

Evonik Invests €93 Million in Vancouver GMP Plant to Triple LNP Capacity

CHEManagerOriginal source

🌍Aug 31Medianovartis.com

25 years of expanding access to cancer care

NovartisOriginal source

🌍Aug 31discoverynews.google.com

760 Yuan Per Pill Pianzihuang Loses Market Popularity – Does the "Pharmaceutical Industry Moutai" Narrative Collapse?

36Original source

🌍Aug 31discoverynews.google.com

BeOne’s cancer regimen gets FDA approval after median survival exceeded two years

Stock TitanOriginal source

🇨🇦Aug 31Industryinvestor.jazzpharma.com

Ziihera® (zanidatamab-hrii) plus Chemotherapy Demonstrates Statistically Significant Overall Survival Benefit Versus Trastuzumab plus Chemotherapy in First-Line HER2+ Advanced GEA

ZymeworksOriginal source

🌍Aug 31discoverynews.google.com

Hong Kong's Lee's Pharmaceutical H1 profit jumps on higher-margin product sales

TradingViewOriginal source

🇺🇸Aug 31CDMOveranex.com

Veranex Appoints Manasi Ramanna as Chief Financial Officer

VeranexOriginal source

🌍Aug 31discoverynews.google.com

BeOne Medicines Announces New Phase 3 Survival Data Reinforcing Benefit of ZIIHERA-Containing Regimens in First-Line HER2+ Gastroesophageal Cancer

FinancialContentOriginal source

🌍Aug 31discoverynews.google.com

IDEAYA Biosciences Announces Successful FDA Type C Meeting for IDE849, DLL3 TOP1 ADC, on Phase 3 Registrational Trial Design for Potential Accelerated and Full Approval in Extensive Stage Small Cell Lung Cancer

PR NewswireOriginal source

🌍Aug 31discoverynews.google.com

Wellington Management Group LLP Raises Stock Position in Teva Pharmaceutical Industries Ltd. $TEVA

MarketBeatOriginal source

🇫🇷Aug 31Regulatoryleem.org

CONFERENCE DE PRESSE : Présentation de la plateforme présidentielle du Leem

LEEM FranceOriginal source

🌍Aug 31discoverynews.google.com

Tempus AI bid to derail DNA patent case hits snag

Life Sciences IP ReviewOriginal source

🌍Aug 31discoverynews.google.com

Kangwon National University to train 205 biotech graduate students with state funding over 5 years

헤럴드경제Original source

🌍Aug 31discoverynews.google.com

Argentina to ease pharma barriers as India trade tops $6.5 bn

pharma.economictimes.indiatimes.comOriginal source

🌍Aug 31discoverynews.google.com

OnRoute Acquires Joanca Logística y Transporte to Strengthen Its Position in the Pharmaceutical and Healthcare Sector

Capital RiesgoOriginal source

🌍Aug 31discoverynews.google.com

Analysts Are Bullish on Top Healthcare Stocks: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990), Innovent Biologics (IVBXF)

The Globe and MailOriginal source

🌍Aug 31discoverynews.google.com

Consun Pharmaceutical Group Ltd. (C1P) Receives a Buy from Guoyuan Securities (HK)

The Globe and MailOriginal source

🌍Aug 31discoverynews.google.com

Zydus’ Saroglitazar posts positive results in Phase 2b fatty liver trials

pharma.economictimes.indiatimes.comOriginal source

🌍Aug 31discoverynews.google.com

Livingston Residents Reminded of Safe Drug Disposal Boxes on International Overdose Awareness Day, Aug. 31

TAPintoOriginal source

🌍Aug 31discoverynews.google.com

Telix Pharmaceuticals Limited (ASX: TLX) Swings to a US$38 Million Profit — Is the ASX Biotech Star Entering a New Earnings Phase?

KalkineOriginal source

🌍Aug 31discoverynews.google.com

Cardiol Therapeutics (TSX:CRDL) Falls 5.92% as Clinical Trial Uncertainty and Biotech Sector Volatility Pressure Investor Sentiment

kalkine.caOriginal source

🌍Aug 31discoverynews.google.com

Harid Anad Explains What Sets Africure Pharmaceuticals Apart in Côte d’Ivoire’s Pharmaceutical Industry

MarcoPolisOriginal source

🌍Aug 31discoverynews.google.com

Foreign Selling and Thinnest Turnover of Year Hit Biotech, Brokerage Stocks

Seoul Economic DailyOriginal source

🌍Aug 31discoverynews.google.com

Biotech Darling Palvella Suddenly Slumps As Optimism Fades

TipRanksOriginal source

🌍Aug 31discoverynews.google.com

Pharmaceutical Industry Accelerates Multi-Billion Dollar Radiopharmaceutical Cancer Therapies

streamlinefeed.co.keOriginal source

🌍Aug 31discoverynews.google.com

Eupraxia Pharmaceuticals Inc. (TSX:EPRX) Faces Downside Pressure as Biotech Volatility and Clinical Execution Risks Weigh on Investor Sentiment

kalkine.caOriginal source

🌍Aug 31discoverynews.google.com

Satellos Bioscience Inc. (TSX:MSCL) Falls 7.42% as Biotech Volatility and Clinical Development Risks Pressure Investor Confidence

kalkine.caOriginal source

🌍Aug 31discoverynews.google.com

Devonian Health Group (TSXV:GSD) Faces Renewed Selling Pressure as Investor Confidence Weakens Amid Biotech Sector Uncertainty

kalkine.caOriginal source

🇩🇪Aug 31pharma_equipmentsyntegon.com

From lab to global scale: building OSD success together

Syntegon (Bosch Packaging)Original source

🌍Aug 31discoverynews.google.com

UToledo College of Pharmacy and Pharmaceutical Sciences Welcomes Largest Pharm.D. Class in 5 Years

UToledo NewsOriginal source

🌍Aug 31discoverynews.google.com

Africure Pharmaceuticals Targets 10% of Côte d’Ivoire’s Pharmaceutical Demand Through Local Production

MarcoPolisOriginal source

🌍Aug 31discoverynews.google.com

Chong Kun Dang signs deal with U.S.-based Kiora to develop, commercialize retinal disease drug candidate in Korea

더바이오Original source

🌍Aug 31discoverynews.google.com

India Presses Brazil for Regulatory Stability to Boost Pharmaceutical Exports

streamlinefeed.co.keOriginal source

🌍Aug 31discoverynews.google.com

When a Failed Primary Endpoint Teaches More Than a Win: What CARDIOTTRansform’s Secondary Analysis Reveals About Stratification in Complex Trials

clinicaltrialvanguard.comOriginal source

🌍Aug 31discoverynews.google.com

This Tiny Biotech Wants To Mine Dogecoin – And Traders Are Loving It

StocktwitsOriginal source

🌍Aug 31discoverynews.google.com

BioNTech cancer vaccine trial halted after survival imbalance

European Biotechnology MagazineOriginal source

🌍Aug 31discoverynews.google.com

The Under-the-Radar Cancer Stock Lighting Up the Forums — Is Racura the Next Biotech Breakout?

KalkineOriginal source

Pharmaceutical industry news

Seizure-related phenomena associated with propofol: insights from the FDA Adverse Event Reporting System (FAERS)

Canaccord reiterates Alnylam stock Buy rating after cardiology data

Eli Lilly buying Merida Biosciences for up to $2.875 billion

Evonik boosts lipid-based drug manufacturing in Canada

Amgen Repatha trial shows 20% lower death risk

Verastem shifts from speculative biotech to com...

Chula Wins at IPSF Asia Pacific Pharmaceutical Symposium - Chulalongkorn University

Karyopharm Submits Supplemental New Drug Application to the FDA for XPOVIO® (selinexor) Plus Ruxolitinib for Patients with Myelofibrosis

Maharashtra FDA steps up festive food safety checks, puts focus on licensed operators

Karyopharm Submits Supplemental New Drug Application to the FDA for XPOVIO® (selinexor) Plus Ruxolitinib for Patients with Myelofibrosis

Origin Agritech opens biotech research center in Guizhou By Investing.com

Hair loss drugs are the next Ozempic. Biotech stocks are climbing

Silicone Tubing for Pharmaceutical Use Market Outlook to 2035

Cipla Inks Licensing Deal for HER2 Cancer Drug TQB2102

Axsome Therapeutics Initiates SUMMIT Phase 3 Trial of AXS-05 in Smoking Cessation

Is Eli Lilly (NYSE:LLY) the Pharmaceutical Bellwether as Approvals Sweep Healthcare?

Unboxing Cancer News, August 2026: Fishy Cancer, Federal- vs. Industry-funded Trials, and More

Rethinking platelet transfusions in newborns

Biotech Startup Investment Held Steady Even As AI Funding Surged

Origin Agritech tests 10,000 corn samples as 300 distributors cover Guizhou

Origin Agritech Establishes R&D Center in Guizhou with Biotech Unit and State-Backed Seed Joint Venture

Alterity Therapeutics (NASDAQ: ATHE) lines up pivotal Phase 3 trial in rare MSA

PANDA Therapeutics secures €160K to advance multi-target Alzheimer’s therapy

Evonik Invests €93 Million in Vancouver GMP Plant to Triple LNP Capacity

25 years of expanding access to cancer care

760 Yuan Per Pill Pianzihuang Loses Market Popularity – Does the "Pharmaceutical Industry Moutai" Narrative Collapse?

BeOne’s cancer regimen gets FDA approval after median survival exceeded two years

Ziihera® (zanidatamab-hrii) plus Chemotherapy Demonstrates Statistically Significant Overall Survival Benefit Versus Trastuzumab plus Chemotherapy in First-Line HER2+ Advanced GEA

Hong Kong's Lee's Pharmaceutical H1 profit jumps on higher-margin product sales

Veranex Appoints Manasi Ramanna as Chief Financial Officer

BeOne Medicines Announces New Phase 3 Survival Data Reinforcing Benefit of ZIIHERA-Containing Regimens in First-Line HER2+ Gastroesophageal Cancer

IDEAYA Biosciences Announces Successful FDA Type C Meeting for IDE849, DLL3 TOP1 ADC, on Phase 3 Registrational Trial Design for Potential Accelerated and Full Approval in Extensive Stage Small Cell Lung Cancer

Wellington Management Group LLP Raises Stock Position in Teva Pharmaceutical Industries Ltd. $TEVA

CONFERENCE DE PRESSE : Présentation de la plateforme présidentielle du Leem

Tempus AI bid to derail DNA patent case hits snag

Kangwon National University to train 205 biotech graduate students with state funding over 5 years

Argentina to ease pharma barriers as India trade tops $6.5 bn

OnRoute Acquires Joanca Logística y Transporte to Strengthen Its Position in the Pharmaceutical and Healthcare Sector

Analysts Are Bullish on Top Healthcare Stocks: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990), Innovent Biologics (IVBXF)

Consun Pharmaceutical Group Ltd. (C1P) Receives a Buy from Guoyuan Securities (HK)

Zydus’ Saroglitazar posts positive results in Phase 2b fatty liver trials

Livingston Residents Reminded of Safe Drug Disposal Boxes on International Overdose Awareness Day, Aug. 31

Telix Pharmaceuticals Limited (ASX: TLX) Swings to a US$38 Million Profit — Is the ASX Biotech Star Entering a New Earnings Phase?

Cardiol Therapeutics (TSX:CRDL) Falls 5.92% as Clinical Trial Uncertainty and Biotech Sector Volatility Pressure Investor Sentiment

Harid Anad Explains What Sets Africure Pharmaceuticals Apart in Côte d’Ivoire’s Pharmaceutical Industry

Foreign Selling and Thinnest Turnover of Year Hit Biotech, Brokerage Stocks

Biotech Darling Palvella Suddenly Slumps As Optimism Fades

Pharmaceutical Industry Accelerates Multi-Billion Dollar Radiopharmaceutical Cancer Therapies

Eupraxia Pharmaceuticals Inc. (TSX:EPRX) Faces Downside Pressure as Biotech Volatility and Clinical Execution Risks Weigh on Investor Sentiment

Satellos Bioscience Inc. (TSX:MSCL) Falls 7.42% as Biotech Volatility and Clinical Development Risks Pressure Investor Confidence

Devonian Health Group (TSXV:GSD) Faces Renewed Selling Pressure as Investor Confidence Weakens Amid Biotech Sector Uncertainty

From lab to global scale: building OSD success together

UToledo College of Pharmacy and Pharmaceutical Sciences Welcomes Largest Pharm.D. Class in 5 Years

Africure Pharmaceuticals Targets 10% of Côte d’Ivoire’s Pharmaceutical Demand Through Local Production

﻿﻿Chong Kun Dang signs deal with U.S.-based Kiora to develop, commercialize retinal disease drug candidate in Korea

India Presses Brazil for Regulatory Stability to Boost Pharmaceutical Exports

When a Failed Primary Endpoint Teaches More Than a Win: What CARDIOTTRansform’s Secondary Analysis Reveals About Stratification in Complex Trials

This Tiny Biotech Wants To Mine Dogecoin – And Traders Are Loving It

BioNTech cancer vaccine trial halted after survival imbalance

The Under-the-Radar Cancer Stock Lighting Up the Forums — Is Racura the Next Biotech Breakout?

Chong Kun Dang signs deal with U.S.-based Kiora to develop, commercialize retinal disease drug candidate in Korea